Cargando…

Adjuvant chemotherapy in patients with operable granulosa cell tumors of the ovary: a surveillance, epidemiology, and end results cohort study

Adjuvant chemotherapy is recommended for patients with resected high‐risk adult granulosa cell tumors (GCT), although strong data to support this are lacking. The objective of this study was to assess the outcomes of GCT patients, with the specific focus on patients that received adjuvant chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oseledchyk, Anton, Gennarelli, Renee L., Leitao, Mario M., Aghajanian, Carol A., Iasonos, Alexia, Zivanovic, Oliver, Zamarin, Dmitriy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010870/ https://www.ncbi.nlm.nih.gov/pubmed/29667339 http://dx.doi.org/10.1002/cam4.1447

Ejemplares similares

Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer
por: Friedman, Claire F, et al.
Publicado: (2020)

Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets
por: Friedman, Claire F., et al.
Publicado: (2023)

Is adjuvant chemotherapy beneficial for patients with FIGO stage IC adult granulosa cell tumor of the ovary?
por: Wang, Dan, et al.
Publicado: (2018)

Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer
por: Kyi, Chrisann, et al.
Publicado: (2021)

Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery
por: Liu, Ying L., et al.
Publicado: (2019)

Granulosa cell tumor of the ovary and antecedent of adjuvant tamoxifen use for breast cancer
por: Abahssain, Halima, et al.
Publicado: (2010)

Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis
por: Gordhandas, Sushmita, et al.
Publicado: (2022)

Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy
por: Ricca, Jacob M., et al.
Publicado: (2018)

The Prognostic Significance of Adjuvant Chemotherapy in Adult Ovarian Granulosa Cell Tumors: A Systematic Review and Meta-analysis
por: Zhuang, Yuan, et al.
Publicado: (2023)

Granulosa cell tumor of the ovary
por: Chou, Cheng-Fa, et al.
Publicado: (2016)

Progestagens for granulosa cell tumours of the ovary.
por: Isaacs, R., et al.
Publicado: (1992)

Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumors
por: Nasioudis, Dimitrios, et al.
Publicado: (2019)

Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer
por: Kim, Jin K, et al.
Publicado: (2022)

Chemotherapy is associated with increased survival from colorectal signet ring cell carcinoma with distant metastasis: A Surveillance, Epidemiology, and End Results database analysis
por: Shi, Tao, et al.
Publicado: (2019)

Impact of adjuvant chemotherapy on outcomes in appendiceal cancer
por: Kolla, Bhaskar C., et al.
Publicado: (2020)

Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers
por: Liu, Ying L., et al.
Publicado: (2018)

Phase II study of neo-adjuvant chemotherapy for locally advanced gastric cancer
por: Chang, Alex Yuang-Chi, et al.
Publicado: (2016)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

Two Cases of Granulosa Cell Tumour of the Ovary
por: Macafee, C. H. G.
Publicado: (1937)

Hepatic Metastases of Granulosa Cell Tumour of the Ovary
por: García, José I. Rodríguez, et al.
Publicado: (1996)

Personalized prescription of imatinib in recurrent granulosa cell tumor of the ovary: case report
por: Poddubskaya, Elena V., et al.
Publicado: (2019)

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy
por: Hsieh, Mao‐Chih, et al.
Publicado: (2018)

Delayed initiation of adjuvant chemotherapy in older women with breast cancer
por: Smith‐Graziani, Demetria, et al.
Publicado: (2020)

Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC
por: Sluiter, Nina R., et al.
Publicado: (2018)

Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs
por: Hao, Zhonglin, et al.
Publicado: (2022)

Adjuvant chemotherapy for early-stage cervical cancer
por: Asano, Hiroshi, et al.
Publicado: (2016)

Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus
por: Oseledchyk, Anton, et al.
Publicado: (2018)

Role of adjuvant chemotherapy in the management of non-granulosa cell ovarian sex cord-stromal tumors
por: Nasioudis, Dimitrios, et al.
Publicado: (2018)

Delayed menopause due to granulosa cell tumor of the ovary
por: Murkey, Bhushan, et al.
Publicado: (2011)

The new molecular biology of granulosa cell tumors of the ovary
por: Kalfa, Nicolas, et al.
Publicado: (2009)

An Unusual Case of Juvenile Granulosa Cell Tumor of the Ovary
por: Rusterholz, Kristin R., et al.
Publicado: (2016)

Synchronous granulosa cell tumor of the ovary and endometrial adenocarcinoma
por: Abuali, Sarah M, et al.
Publicado: (2022)

Impact of adjuvant chemotherapy on the survival of patients with breast cancer diagnosed by screening
por: Zarcos‐Pedrinaci, Irene, et al.
Publicado: (2019)

Efficacy of surgery and chemotherapy for stage IV small bowel adenocarcinoma: A population‐based analysis using Surveillance, Epidemiology, and End Result Program database
por: Liu, Tongtong, et al.
Publicado: (2020)

Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer
por: Xiong, Ying, et al.
Publicado: (2020)

Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade
por: Boland, Julia L., et al.
Publicado: (2018)

Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial
por: Zamarin, Dmitriy, et al.
Publicado: (2020)

Effect of chemotherapy and aromatase inhibitors in the adjuvant treatment of breast cancer on glucose and insulin metabolism—A systematic review
por: Buch, Kristian, et al.
Publicado: (2018)

Can adjuvant chemotherapy improve the prognosis of adult ovarian granulosa cell tumors?: A narrative review
por: Zhuang, Yuan, et al.
Publicado: (2022)

Predictive impact of the inflammation‐based indices in colorectal cancer patients with adjuvant chemotherapy
por: Tao, Yong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gk0g41pigce1788qpkjcivv5d9